Mirae Asset Healthcare Fund
- NAV as on 9 Nov 2026
- ₹48.84+2.99%1 day
- Return since launch
- 20.5%
- 52-week range
- ₹36.01 — ₹47.43
- AUM
- ₹3,494 Cr
Mirae Asset Healthcare Fund is a Sectoral-Pharma equity fund from Mirae Asset Mutual Fund with ₹3,494 Cr under management, launched in 2018. Over three years it has returned 20.2% a year, against 21.2% for its category. The expense ratio is 2.04% and the SEBI riskometer reading is Very High.
Performance
Mirae Asset Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +26.9% against +19.9% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 37.3% | +16.5 pts | 20.8% | 29.1% |
| 2Y | 23.1% | +4.1 pts | 19.1% | 17.6% |
| 3Y | 20.2% | −1.0 pts | 21.2% | 16.0% |
| 5Y | 21.1% | +5.7 pts | 15.4% | 18.5% |
| 7Y | 20.6% | +1.8 pts | 18.9% | 18.0% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 10.0% | +1.6 pts | 8.4% | 8.5% |
| 3M | 7.0% | +3.2 pts | 3.7% | 3.7% |
| 6M | 16.3% | +2.3 pts | 14.0% | 13.6% |
| 1Y | 26.2% | +5.4 pts | 20.8% | 19.4% |
| 2Y | 13.4% | +2.6 pts | 10.8% | 9.5% |
| 3Y | 22.8% | +1.5 pts | 21.2% | 20.0% |
| 5Y | 16.1% | +0.7 pts | 15.4% | 14.6% |
| 7Y | 24.4% | +2.1 pts | 22.4% | 21.2% |
Since launch (11 Jun 2018): 20.5%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -3.4% | −1.4 pts | -2.0% |
| 2024 | 38.7% | −2.1 pts | 40.9% |
| 2023 | 34.0% | −2.2 pts | 36.2% |
| 2022 | -11.8% | −3.5 pts | -8.3% |
| 2021 | 26.6% | +4.9 pts | 21.7% |
| 2020 | 73.9% | +5.1 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.01%
Expense ratio as on 6 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.64%
- Brokerage
- 0.02%
- Transaction charges
- 0.00%
- Statutory levies
- 0.35%
- Exit load
- Exit load of 1% if redeemed within 1 Month.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -0.15 | 1.90 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.96 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.00 | 1.13 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.62 | 1.86 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 15.91 | 15.54 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
Mirae Asset Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity100.0%
- Debt0.0%
- Other0.0%
Market cap split
- Large35.0%
- Mid42.1%
- Small22.9%
- P/E
- 47.55
- P/B
- 5.81
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 10.15% | ₹355 Cr | +10.95% | +12.20% | +11.57% |
| Divi's Laboratories Ltd. | Healthcare | 9.79% | ₹342 Cr | +7.53% | +7.93% | +7.76% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 6.80% | ₹238 Cr | +0.46% | +0.49% | +2.81% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 5.62% | ₹196 Cr | +6.09% | +6.15% | +6.23% |
| Laurus Labs Ltd. | Healthcare | 5.51% | ₹193 Cr | +4.61% | +3.56% | +2.29% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 4.84% | ₹169 Cr | +4.33% | +4.31% | +4.19% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 4.78% | ₹167 Cr | +6.09% | +6.94% | +6.97% |
| Aurobindo Pharma Ltd. | Healthcare | 3.78% | ₹132 Cr | +4.33% | +4.32% | +4.33% |
| Alkem Laboratories Ltd. | Healthcare | 3.76% | ₹131 Cr | +3.54% | +3.25% | +2.80% |
| Ipca Laboratories Ltd. | Healthcare | 3.39% | ₹118 Cr | +3.23% | +3.32% | +3.49% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 3.39% | ₹118 Cr | +3.85% | +3.26% | +3.74% |
| Aster DM Quality Care Ltd. | Healthcare | 3.32% | ₹116 Cr | +3.17% | +3.44% | +3.40% |
| Sai Life Sciences Ltd. | Healthcare | 3.23% | ₹113 Cr | +3.26% | +3.03% | +2.45% |
| Onesource Specialty Pharma Ltd. | Healthcare | 3.01% | ₹105 Cr | +3.35% | +2.91% | +2.74% |
| Fortis Healthcare Ltd. | Healthcare | 2.94% | ₹103 Cr | +3.80% | +3.73% | +4.19% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 2.90% | ₹101 Cr | +2.57% | +1.95% | — |
| Gland Pharma Ltd. | Healthcare | 2.69% | ₹93.92 Cr | +2.49% | +1.88% | +1.70% |
| Cipla Ltd. | Healthcare | 2.63% | ₹92.01 Cr | +3.19% | +3.37% | +6.03% |
| Eris Lifesciences Ltd. | Healthcare | 2.39% | ₹83.38 Cr | +3.16% | +2.67% | +3.01% |
| Max Healthcare Institute Ltd. | Healthcare | 2.35% | ₹81.96 Cr | +3.06% | +1.11% | — |
| Lupin Ltd. | Healthcare | 2.27% | ₹79.21 Cr | +4.13% | +5.06% | +5.05% |
| Mankind Pharma Ltd. | Healthcare | 2.24% | ₹78.35 Cr | +2.11% | +1.67% | +1.62% |
| Biocon Ltd. | Healthcare | 2.00% | ₹70.05 Cr | +0.52% | +1.27% | +0.92% |
| Molbio Diagnostics Ltd. | Healthcare | 1.77% | ₹61.89 Cr | — | — | — |
| Symbiotec Pharmalab Ltd. | Healthcare | 1.60% | ₹55.81 Cr | — | — | — |
| Neogen Chemicals Ltd. | Chemicals | 1.50% | ₹52.53 Cr | +0.64% | +0.42% | +0.56% |
| Anthem Biosciences Ltd. | Healthcare | 0.93% | ₹32.45 Cr | +1.16% | +1.25% | +1.45% |
| Deepak Nitrite Ltd. | Chemicals | 0.40% | ₹14.00 Cr | +0.44% | +0.43% | +0.83% |
| Others | Others | 0.02% | ₹0.72 Cr | -0.29% | -0.60% | -0.31% |
| Mirae Asset Liquid Fund Direct- Growth | Unclassified | 0.01% | ₹0.25 Cr | +0.01% | +0.01% | +0.01% |
| Narayana Hrudayalaya Ltd. | Healthcare | 0.00% | ₹0.04 Cr | +1.22% | +1.17% | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Narayana Hrudayalaya Ltd. | 0.91% | 0.00% | -0.91% |
| Dr. Reddy's Laboratories Ltd. | 3.94% | 4.84% | +0.90% |
| Neogen Chemicals Ltd. | 0.64% | 1.50% | +0.87% |
| Sun Pharmaceutical Industries Ltd. | 10.90% | 10.15% | -0.75% |
| Symbiotec Pharmalab Ltd. | 0.98% | 1.60% | +0.61% |
| Fortis Healthcare Ltd. | 3.40% | 2.94% | -0.46% |
| Others | -0.12% | -0.55% | -0.42% |
| Alkem Laboratories Ltd. | 3.39% | 3.76% | +0.37% |
| Molbio Diagnostics Ltd. | 1.44% | 1.77% | +0.33% |
| Aster DM Quality Care Ltd. | 3.01% | 3.32% | +0.32% |
| Apollo Hospitals Enterprise Ltd. | 5.91% | 5.62% | -0.29% |
| Laurus Labs Ltd. | 5.24% | 5.51% | +0.27% |
| Torrent Pharmaceuticals Ltd. | 7.06% | 6.80% | -0.25% |
| Gland Pharma Ltd. | 2.44% | 2.69% | +0.25% |
| Max Healthcare Institute Ltd. | 2.58% | 2.35% | -0.24% |
| Krishna Institute of Medical Sciences Ltd | 3.16% | 3.39% | +0.23% |
| Glenmark Pharmaceuticals Ltd. | 4.99% | 4.78% | -0.21% |
| Anthem Biosciences Ltd. | 1.13% | 0.93% | -0.20% |
| Eris Lifesciences Ltd. | 2.55% | 2.39% | -0.17% |
| Lupin Ltd. | 2.40% | 2.27% | -0.13% |
| Dr. Lal Pathlabs Ltd. | 2.77% | 2.90% | +0.13% |
| Biocon Ltd. | 2.13% | 2.00% | -0.13% |
| Divi's Laboratories Ltd. | 9.91% | 9.79% | -0.12% |
| Mankind Pharma Ltd. | 2.13% | 2.24% | +0.11% |
| Cipla Ltd. | 2.71% | 2.63% | -0.08% |
| Sai Life Sciences Ltd. | 3.30% | 3.23% | -0.07% |
| Onesource Specialty Pharma Ltd. | 2.96% | 3.01% | +0.06% |
| Deepak Nitrite Ltd. | 0.45% | 0.40% | -0.05% |
| Ipca Laboratories Ltd. | 3.43% | 3.39% | -0.04% |
| Aurobindo Pharma Ltd. | 3.81% | 3.78% | -0.04% |
| Mirae Asset Liquid Fund Direct- Growth | 0.01% | 0.01% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,794 Cr | 1.86% | 36.3% | 21.0% | 21.8% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Fund managers
- Vrijesh KaseraMr. Kasera is a MBA (Finance), CFA (ICFAI).Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months16.28% absolute | ₹60,000 | ₹69,768 | 16.28% | |
| 1 year26.18% annualised | ₹1,20,000 | ₹1,38,456 | 15.38% | |
| 3 years22.77% annualised | ₹3,60,000 | ₹5,19,489 | 44.30% | |
| 5 years16.14% annualised | ₹6,00,000 | ₹9,26,159 | 54.36% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.